Infusion for Health

Infusion for Health, based in the US, specializes in providing comprehensive infusion therapy services, enhancing the patient experience through both private infusion suites and home care options. Infusion for Health is engaged in offering infusion therapy services tailored to patients with chronic health conditions. Founded in California City, US in 2015, the company has effectively secured a total of USD 50. 00 mn through its GROWTH funding round, led by Oak HC/FT Partners, with Cimarron Healthcare Capital also participating.

The most recent deal was completed on November 2, 2021. CEO Dan McCarty leads the company, which has executed 2 total deals since its inception. Infusion for Health focuses on delivering infusion therapy services designed to improve the patient experience during treatment. The company provides private infusion suites and home infusion services that allow patients to receive treatments such as Stelara, Remicade, and IVIG in a comfortable setting, whether at their center or at home.

Their primary customer base includes patients with chronic conditions needing ongoing therapies, as well as healthcare providers who refer these patients. Infusion for Health operates in multiple states, including Arizona, California, Colorado, Missouri, Nevada, and Washington, working closely with healthcare providers to create an integrated approach to patient care. Infusion for Health generates revenue through its infusion therapy services, utilizing a direct-to-consumer model alongside partnerships with healthcare providers. Services are typically billed through insurance providers or self-pay options when patients are referred for treatment.

The pricing structure reflects the complexity of the services provided, which include personalized treatment plans and specialty medication administration. The company aims for a seamless referral process and continuity of care, which supports efficient transaction handling and service delivery throughout its network of infusion centers. Infusion for Health plans to utilize the capital raised in November 2021 to expand its market reach. The company is focusing on enhancing its services and possibly exploring new geographic regions for growth.

Specific future product launches or dates have not been detailed, but the intention is clear in leveraging the recent funding to support these initiatives.